The Board at its meeting held on August 14, 2026 approved Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026.

Date: August 14, 2026 The General Manager DCS - CRD BSE LIMITED Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip code: 524336 Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board at its meeting held on August 14, 2026 approved the following: 1. Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026. 2. Pursuant to Regulation 32(1) the SEBI Listing Regulations, a statement indicating the utilization of issue proceeds of Preferential Issue and statement indicating nil deviation and variation. The Meeting commenced at 01.30 p.m. and concluded at 03.30 p.m. Enclosures: 1. Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026. 2. Limited Review Reports (Standalone and Consolidated) for the quarter ended June 30, 2026. 3. Pursuant to Regulation 32(1) the SEBI Listing Regulations, a statement indicating the utilization of issue proceeds of Preferential Issue and statement indicating nil deviation and variation. Thanking you. Yours faithfully, FOR SHREE HARI CHEMICALS EXPORT LIMITED B.C. AGRAWAL Chairman & Managing Director DIN: 00121080 KAILASH CHAND JAIN & CO. (Regd) Prone 0222200011 CHARTERED ACCOUNTANTS 022-22065373 EDENA, 1st Floor, 97, Maharshi Karve Road, Near Income Tax Office, Mumbai - 400 020. e-mail : mail@kcjainco.com Independent Auditor’s Review Report on the unaudited Standalone quarterly financial results of Shree Hari Chemicals Export Limited Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended The Board of Directors Shree Hari Chemicals Export Limited 1. We have reviewed the accompanying statement of unaudited standalonc financial results of Shree Hari Chemicals Export Limited (the ‘Company’) for the quarter ended June 30. 2026 attached herewith being submitted by the Company pursuant to requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015, as amended. 2. This Statement, which is the responsibility of the Company’s Management and approved by the Company’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34. (Ind AS-34) “Interim Financial Reporting” prescribed under section 133 of Companies Act. 2013 as amended, read with relevant rules issued thereunder and other accounting principles gencrally accepted in India. Our responsibility is to express a conclusion on the statement based on our review 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, “Review of Interim Financial Information Performed by Independent Auditor of the Entity™ issucd by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review (o obtain moderate assurance as to whether the Statement is free of material misstatement. A review is limited primarily to inquire of company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and accordingly. we do not express an audit opinion. 4. Based on our review conducted as above. nothing has come to our attention that causes us to believe that the accompanying statement of standalonc unaudited financial results prepared in accordance with applicable accounting standards and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to be disclosed. or that it contains any material misstatement. For Kailash Chand Jain & Co. Chartered Accountants Firm Registration No.: 112318W Yash Sii Partner Membership No.: 159392 Date: August 14, 2026 Place: Mumbai 2 c UDIN: 261533Q9X 2 LINF2626 Branches: Delhi + Kolkata * Indore ¢ Bhopal + Raipur SHREE HARI CHEMICALS EXPORT LIMITED CORPORATE OFF.: 401/402, A-Wing, Oberoi Chambers, Opposite SAB TV, New Link Road, Andheri West, Mumbai 400 053. = Tel.: (91-22) 49634834 e E-mail: info@shreeharichemicals.in =H : e Website: www.shreeharichemicals.in @ CIN No. L99999MH1987PLC044942 UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2026 (Rs. In Lakhs) (Except EPS) NS OR .. PARTICULARS 30.06.2026 'UA 3R 1T 0E 3R E 02N 6D ED 30062025 YE 3A 1.R 3E .2N 0D 26E D UNAUDITED AUDITED UNAUDITED AUDITED 21 [ |Ot| herR Ine cF orv mo em e Opneruatieon 549 640 .8 44 T1 22 01 15 34 243 21 126 10 184 35 00 54 88 3 [Total Income (1+2) 555533 432291 2,452.80 18,756.27 4 |Expenses @ [Cost of Materials Consumed 328697 251292 1975.03 9.275.48 ¢b [P Cu hr ac nh ga es se io nf iS nt vo ec nk t- oi rin e- sT r oa fd Fe i nish goods, work-in-progress and stock-in-trade (21 82 70 .. 11 8)6 17( 43 .. 49 27 ) (1,7 34 30 7. .8 78 33 (1 25 091 28 d [Employees benefit expenses 448.18 49181 41500 173191 e [Finance cost 5437 53.68 56,18 21567 f [Depreciation and amortisation expenses 7134 6984 5514 23538 & [Other expenses 107082 20518 760 44 347398 Total Expenses (a+g) 4,764.66 4,193.90 267397 18.226.69 5 |Profiti(Loss) before exceptional items, extraordinary items and tax (34) 790.67 129.01 (221.16) 52959 6 |Exceptional/ Extraordinary ltems 7 |Profit/(Loss) before tax (5-6) 790.67 129.01 (221.16), 529.59 8 |Taxexpenses a b [Cu Dr er fen et r T ra teax dx 201- 4 3 23g 4 2 (5490) 107. 37 ¢ [ ToS th ao lr t te ax xc ees xs ep nr so ev si sion for carlicr periods 20( 10 .. 40 31 ) 23- 107.- 9 Net Profit/(Loss) for the Period (7-8) 589.24 105.59 (166.27)] 421.22 10 |Other Comprehensive Income a [ltems that will not be reclassified to profit or loss i) Remeasurement of the efined benefit plans - (161 (161) i) Income tax relating to items that will not be reclassified to profit or loss - 041 041 Total other comprehensive income, net of income tax B (1.20) (1.20) 11 (Total Comprehensive income for the period (9+10) 580.24 104.39 (166.27) 421.01 12 [Paid up Equity Share Capital (Face Value Rs. 10 each) 631.29 553.79 49324 55379 Face Value of share (%) 10.00 1000 1000 10.00 13 [Reserves excluding Revaluation Reserve 3,886.40 14 |Eamings per share (oRfs 10 each) (not annualised) ) Basic 936 191 (3.37) 823 b) Diluted 936 1.67 (2.63) 718 By the Order of the Board For Shree Hari Chemicals Export Limited Date: 14th August 2026 REGD. OFF. & WORKS : A8, M.L.D.C. INDUSTRIAL AREA, MAHAD, DIST : RAIGAD (M.S.) SHREE HARI CHEMICALS EXPORT LIMITED CORPORATE OFF.: 401/402, A-Wing, Oberoi Chambers, Opposite SAB TV, New Link Road, Andheri West, Mumbai 400 053 Tel.: (91-22) 49634834 @ E-mail: info@shreeharichemicals.in Website: www.shreeharichemicals.in ® CIN No. L99999MH1987PLC044942 Notes: 1 The Standalone financial results of the Company have been prepared in accordance with the Companies (Indian Accounting Standard) Rules' 2015 (IND-AS) prescribed under section 133 of the Companies Act, 2013 and other recognized accounting practices and policies to the extent applicable. 2 The above standalone financial results have been reviewed by the Audit Committee and subsequently approved by the Board of Directors at its meeting held on August 14, 2026. 3 The Company operates in a single business segment and therefore, has only one reportable segment in accordance with Ind AS 108 "Operating Segments" 4 The Company had alloted 18,66,580 Zero Coupon Compulsorily Convertible Debentures ("CCDs") on November 15, 2024, out of which 7,74,946 Equity shares were alloted upon conversion of equal number of CCDs on April 03, 2026. 5 The figures for the previous period has been regrouped/reclassified, wherever necessary in order to conform to the current grouping/ classification. 6 Other income includes the rate fluctuation of forex. By order of the Board for SHREE H [Showing first 8,000 characters — download PDF for full document]